id: NEW:peripheral_iv_catheter_replacement_policy_to_NEW:thrombophlebitis_rate
name: Peripheral IV Catheter Replacement Policy (Clinically-Indicated vs Routine) â†’ Thrombophlebitis Rate
from_node:
  node_id: NEW:peripheral_iv_catheter_replacement_policy
  node_name: Peripheral IV Catheter Replacement Policy (Clinically-Indicated vs Routine)
to_node:
  node_id: NEW:thrombophlebitis_rate
  node_name: Thrombophlebitis Rate
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: Healthcare policy determines catheter replacement timing'
- 'Step 2: Longer catheter dwell time with clinically-indicated approach may increase vessel irritation
  exposure'
- 'Step 3: Endothelial damage and inflammatory response can lead to thrombophlebitis'
- 'Step 4: No significant difference in thrombophlebitis rates observed between replacement strategies'
evidence:
  quality_rating: A
  n_studies: 7
  primary_citation: Joan Webster et al. 2019. "Clinically-indicated replacement versus routine replacement
    of peripheral venous catheters.." https://doi.org/10.1002/14651858.CD007798.pub5
  supporting_citations:
  - Rickard CM et al. (2012). Lancet
  - Two trials excluded from meta-analysis due to high heterogeneity
  - Additional citations require full-text access
  doi: 10.1002/14651858.CD007798.pub5
  citation_verified: true
last_updated: '2025-12-06'
version: '2.0'
description: No clear difference in thrombophlebitis rates between clinically-indicated (317/3590) and
  routine replacement (307/3733) groups (RR 1.07, 95% CI 0.93-1.25). When analyzed by device days (32,709
  total), results remained non-significant (RR 0.90, 95% CI 0.76-1.08)
quantitative_effects:
  effect_size:
    value: 1.07
    type: relative_risk
    ci_lower: 0.93
    ci_upper: 1.25
  sample_size: 7323
moderators:
- name: infusion_type
  direction: neutral
  strength: weak
  description: Result was unaffected by whether infusion was continuous or intermittent
structural_competency:
  equity_implications: This healthcare protocol-level policy affects all hospitalized patients requiring
    IV access. The finding of no difference challenges routine replacement guidelines that create unnecessary
    healthcare utilization and patient burden.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:37.911539'
  extraction_confidence: medium
  prompt_version: 2.1-canonical-validated
